看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 0.4x - 0.4x | 0.4x |
| Selected Fwd Revenue Multiple | 0.4x - 0.4x | 0.4x |
| Fair Value | ₩10,838 - ₩12,774 | ₩11,806 |
| Upside | 37.4% - 61.9% | 49.6% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Dong-A ST Co., Ltd. | A170900 | KOSE:A170900 |
| Huons Global Co., Ltd. | A084110 | KOSDAQ:A084110 |
| Kyung Dong Pharmaceutical Co., Ltd. | A011040 | KOSDAQ:A011040 |
| Dongwha Pharm.Co.,Ltd | A000020 | KOSE:A000020 |
| JW Lifescience Corporation | A234080 | KOSE:A234080 |
| Jeil Pharma Holdings Inc | A002620 | KOSE:A002620 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| A170900 | A084110 | A011040 | A000020 | A234080 | A002620 | |||
| KOSE:A170900 | KOSDAQ:A084110 | KOSDAQ:A011040 | KOSE:A000020 | KOSE:A234080 | KOSE:A002620 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 2.7% | 12.6% | 1.9% | 8.6% | 5.5% | 1.3% | ||
| 3Y CAGR | 5.6% | 12.3% | 3.0% | 16.6% | 9.4% | 0.7% | ||
| Latest Twelve Months | 5.1% | 7.3% | 19.2% | 28.7% | 7.5% | -3.0% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 2.4% | 14.5% | 3.1% | 6.9% | 16.7% | 0.4% | ||
| Prior Fiscal Year | 1.7% | 15.3% | -15.3% | 5.2% | 14.9% | 2.6% | ||
| Latest Fiscal Year | -3.6% | 12.0% | 1.4% | 2.9% | 16.1% | -1.4% | ||
| Latest Twelve Months | -3.6% | 12.0% | 1.4% | 2.9% | 16.1% | -1.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 0.81x | 1.15x | 0.48x | 0.41x | 1.06x | 0.30x | ||
| EV / LTM EBIT | -22.6x | 9.6x | 35.4x | 14.1x | 6.6x | -21.2x | ||
| Price / LTM Sales | 0.59x | 0.70x | 0.80x | 0.37x | 0.80x | 0.16x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 0.41x | 0.81x | 1.15x | |||||
| Historical EV / LTM Revenue | 0.30x | 0.43x | 0.63x | |||||
| Selected EV / LTM Revenue | 0.37x | 0.39x | 0.41x | |||||
| (x) LTM Revenue | 779,822 | 779,822 | 779,822 | |||||
| (=) Implied Enterprise Value | 291,410 | 306,747 | 322,085 | |||||
| (-) Non-shareholder Claims * | (116,020) | (116,020) | (116,020) | |||||
| (=) Equity Value | 175,390 | 190,727 | 206,064 | |||||
| (/) Shares Outstanding | 15.4 | 15.4 | 15.4 | |||||
| Implied Value Range | 11,425.19 | 12,424.30 | 13,423.40 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 11,425.19 | 12,424.30 | 13,423.40 | 7,890.00 | ||||
| Upside / (Downside) | 44.8% | 57.5% | 70.1% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A170900 | A084110 | A011040 | A000020 | A234080 | A002620 | |
| Enterprise Value | 565,651 | 934,799 | 92,861 | 188,860 | 236,046 | 237,141 | |
| (+) Cash & Short Term Investments | 301,078 | 278,678 | 30,913 | 43,497 | 9,622 | 75,883 | |
| (+) Investments & Other | 82,549 | 101,796 | 69,556 | 65,942 | 559 | 93,756 | |
| (-) Debt | (495,663) | (297,387) | (38,677) | (96,989) | (69,238) | (155,212) | |
| (-) Other Liabilities | (38,522) | (444,056) | (276) | (28,304) | 0 | (130,447) | |
| (-) Preferred Stock | 0 | (6,850) | 0 | (1,154) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 415,093 | 566,980 | 154,376 | 171,851 | 176,988 | 121,120 | |
| (/) Shares Outstanding | 9.2 | 12.2 | 26.9 | 27.7 | 15.5 | 15.4 | |
| Implied Stock Price | 45,300.00 | 46,550.00 | 5,730.00 | 6,200.00 | 11,430.00 | 7,890.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 45,300.00 | 46,550.00 | 5,730.00 | 6,200.00 | 11,430.00 | 7,890.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |